Related Experiment Video
Updated: Jan 28, 2026

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
Imaging inflammation using an activated macrophage probe with Slc18b1 as the activation-selective gating target
Sung-Jin Park1, Beomsue Kim1, Sejong Choi2
1Laboratory of Bioimaging Probe Development, Singapore Bioimaging Consortium, Agency for Science, Technology and Research, Singapore, 138667, Republic of Singapore.
Abstract:
Activated macrophages have the potential to be ideal targets for imaging inflammation. However, probe selectivity over non-activated macrophages and probe delivery to target tissue have been challenging. Here, we report a small molecule probe specific for activated macrophages, called CDg16, and demonstrate its application to visualizing inflammatory atherosclerotic plaques in vivo. Through a systematic transporter screen using a CRISPR activation library, we identify the orphan transporter Slc18b1/SLC18B1 as the gating target of CDg16.
Insights
Researchers developed a new small molecule probe, CDg16, that specifically targets activated macrophages for imaging inflammation. This probe visualizes atherosclerotic plaques in vivo by identifying the SLC18B1 transporter.
Area of Science:
- Molecular biology
- Immunology
- Medical imaging
Background:
- Activated macrophages are key targets for inflammation imaging.
- Challenges include probe selectivity and delivery to target tissues.
Purpose of the Study:
- To develop a novel small molecule probe for activated macrophage imaging.
- To demonstrate its utility in visualizing inflammatory atherosclerotic plaques.
Main Methods:
- Systematic transporter screen using a CRISPR activation library.
- Development and in vivo application of the CDg16 probe.
- Identification of the SLC18B1 transporter as the CDg16 target.
Main Results:
- A small molecule probe, CDg16, was identified with specificity for activated macrophages.
- CDg16 successfully visualized inflammatory atherosclerotic plaques in vivo.
- The orphan transporter Slc18b1/SLC18B1 was identified as the gating target of CDg16.
Conclusions:
- CDg16 is a selective probe for activated macrophages, overcoming previous challenges.
- This probe enables in vivo imaging of inflammatory conditions like atherosclerosis.
- Understanding the SLC18B1 transporter is crucial for CDg16's mechanism of action.
More Related Videos
08:52Neuron-Macrophage Co-cultures to Activate Macrophages Secreting Molecular Factors with Neurite Outgrowth Activity
Published on: March 30, 2018
07:46Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Co-activators and Co-repressors
tRNA Activation
Activation Energy
Inflammation
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...